Dan Bolland

Dan has 25 years of experience and expertise working at the forefront of genomics, immunology, V(D)J recombination and NGS technologies.

Dan obtained his PhD in genomics at the Institute of Genetics, University of Nottingham. A large part of his postdoctoral work at the Babraham Institute, Cambridge was spent working on the regulation of recombination of antibody loci, antibody repertoire selection, and B lymphocyte development and he developed novel high impact assays that enabled the discovery of new mechanisms underlying these processes.

At PetMedix since 2020, Dan is the head of pipeline development and oversees the cell sorting and NGS pipeline as well as two external discovery projects.